Inventor · Harlow, GB

David Clark

20Patents
13h-index
15Co-inventors
78Inventor score

Filing activity: Nov 15, 1999 → Apr 30, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US7678813B2 Azadecalin Glucocorticoid receptor modulators Chemistry; Metallurgy 38 Expired
US6881554B2 Apparatus and methods for chemiluminescent assays Emerging Cross-Sectional Technologies 33 Expired
US6955811B2 Methods of inhibiting immune response suppression by administering antibodies to OX-2 Chemistry; Metallurgy 33 Expired
US7576076B2 Modified pyrimidine glucocorticoid receptor modulators Chemistry; Metallurgy 32 Active
US7238352B2 Methods and compositions for modulating tumor growth Chemistry; Metallurgy 27 Expired
US6548018B2 Apparatus for chemiluminescent assays Emerging Cross-Sectional Technologies 26 Expired
US6749854B2 Use of OX-2 to inhibit fetal loss Chemistry; Metallurgy 25 Expired
US6652858B2 Use of OX-2 to suppress an immune response Chemistry; Metallurgy 24 Expired
US6887681B2 Apparatus and methods for chemiluminescent assays Emerging Cross-Sectional Technologies 24 Expired
US8324203B2 Azadecalin glucocorticoid receptor modulators Chemistry; Metallurgy 19 Active
US7452536B2 Methods of treating cancer by administering antibodies to CD200 Chemistry; Metallurgy 16 Active
US7485262B2 Apparatus for chemiluminescent assays Emerging Cross-Sectional Technologies 16 Expired
US7887798B2 Methods of treating cancer by administering antibodies to CD200 Chemistry; Metallurgy 15 Active
US8173664B2 Modified pyrimidine glucocorticoid receptor modulators Chemistry; Metallurgy 11 Active
US6403089B1 Methods of modulating immune coagulation Physics 9 Expired
US7902151B2 Methods and compositions for modulating immunity Chemistry; Metallurgy 8 Active
US7291330B2 MD-1 inhibitors as immune suppressants Chemistry; Metallurgy 1 Expired
US7553811B2 Methods and compositions for modulating immunity Chemistry; Metallurgy 0 Active
US11719707B2 Methods for the diagnosis and treatment of endometriosis Physics 0 Active
US8187598B2 Methods of treating cancer by administering antibodies to CD200 Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.